Antiparasitic Wins FDA Approval for High-Risk Neuroblastoma
The US Food and Drug Administration (FDA) approved eflornithine (Iwilfin) to reduce the risk for relapse in patients with high-risk ...
Read moreThe US Food and Drug Administration (FDA) approved eflornithine (Iwilfin) to reduce the risk for relapse in patients with high-risk ...
Read more© 2023 earth-news.info